Navigation Links
Hepatitis B Foundation Testifies Before Congressional Appropriation Committee and Urges More Federal Funding for Hepatitis B
Date:3/20/2008

DOYLESTOWN, Pa., March 20 /PRNewswire-USNewswire/ -- Hepatitis B Foundation President Dr. Timothy Block testified about the public health challenge of chronic hepatitis B before the Congressional Appropriations Subcommittee on Labor, Health and Human Services on March 13 in Washington, DC, at the request of Honorable David Obey, chairman, Committee on Appropriations. Dr. Block spoke about the urgent need to strengthen and increase funding for hepatitis B programs at the Centers for Disease Control and Prevention (CDC) and the National Institutes of Health (NIH).

"The recent crisis in a Nevada clinic, where 40,000 people were placed at risk for infection with hepatitis B and C, is a problem that the CDC thinks might just be the tip of the iceberg," said Dr. Block. "This incident highlights critical deficiencies in our public health and research programs, and if we don't act with urgency, more and more people will suffer."

The Foundation believes that a well-equipped CDC is our best hope to manage the public health problem of hepatitis B. Two million chronically infected Americans are depending upon the NIH to search for new interventions to treat hepatitis B and liver cancer, a fatal outcome of chronic hepatitis B and the fastest growing cancer in the U.S. today. Both the CDC and NIH have performed admirably with the limited resources they are provided; however, much more is needed to achieve effective, lasting solutions.

Dr. Block concluded his testimony by urging the appropriations subcommittee to restore in FY 2009 the overall CDC budget to $7.4 billion with a $50 million increase for the Division of Viral Hepatitis, and to provide a 6.7% increase for the NIH bringing the total to $31.2 billion, including a $40 million annual increase for hepatitis B research.

Chairman David Obey was sympathetic and commented on the importance of restoring cuts to the NIH and CDC budget to address important health issues.

About the Hepatitis B Foundation

The Hepatitis B Foundation is a national nonprofit organization dedicated to finding a cure and improving the quality of life for those affected with hepatitis B worldwide through research, education and patient advocacy. For more information, visit http://www.hepb.org or call (215) 489-4900.

Contact: Leah Rice

(215) 340-0480

leah@furiarubel.com Available Topic Expert(s): For information on the listed expert(s), click appropriate link. Dr. Timothy Block http://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=66704 Joan Block http://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=66707


'/>"/>
SOURCE Hepatitis B Foundation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. XTL Biopharmaceuticals Signs $108 Million Deal for the Licensing of its Pre- Clinical Program in Hepatitis C to Presidio Pharmaceuticals
2. Oncolys BioPharma and Tacere Therapeutics Sign Strategic Alliance and License Agreement to Develop and Commercialize RNAi Hepatitis C Drug
3. Schering-Plough and OraSure Technologies Sign International Collaboration for Rapid Point-of-Care Oral Hepatitis C Test
4. Conatus Pharmaceuticals Initiates a Phase 2 Clinical Trial for the Treatment of Hepatitis
5. The University of Nottingham in the British Midlands Announces Development of Possible Hepatitis C Vaccine
6. Touching 418 Million Lives, Hepatitis Still Presents Significant Threat to Global Health
7. Touching 418 Billion Lives, Hepatitis Still Presents Significant Threat to Global Health
8. Pharmasset and Roche to Present R7128 Data at the 14th International Symposium on Hepatitis C Virus and Related Viruses
9. XTL Biopharmaceuticals Announces Presentation of Novel Pre-Clinical Inhibitors of Hepatitis C at an Upcoming International Scientific Conference
10. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
11. Roche Joins Forces With Enon Tabernacle Baptist Church to Provide Free Hepatitis C Testing to the Community
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... WASHINGTON , Feb. 11, 2016   BioInformant ... strategic report, "Stem Cell Research Products, Opportunities, Tools, and ... 2020. ... specialize in the stem cell industry, BioInformant has more ... of the stem cell market, by stem cell type. ...
(Date:2/11/2016)... , ... February 11, 2016 , ... ... its new stem cell treatment clinic in Quito, Ecuador. The new facility will ... trauma applications to patients from around the world. , The new GSCG ...
(Date:2/10/2016)... 10, 2016  The Maryland House of Delegates and ... that University of Maryland School of Medicine Dean ... of Maryland Medical System President and CEO Robert ... the highest honor given to the public by the ... Dean Reece and Mr. Chrencik for their contributions ...
(Date:2/10/2016)... York, and New York, New York (PRWEB) , ... ... ... Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) today announced that it has ... develop new vaccines and immunotherapies for infectious diseases and cancer. , ...
Breaking Biology Technology:
(Date:2/11/2016)... , Feb. 11, 2016  Vigilant Solutions announces today that ... are being used by Lee,s Summit ... recent location and arrest of a homicide suspect. ... covers around 65 square miles and is home to ... Department has a single mobile license plate reader system and ...
(Date:2/5/2016)... 2016 http://www.researchandmarkets.com/research/5kvw8m/global_facial ) ... "Global Facial Recognition Market 2016-2020" report ... ) has announced the addition of the ... report to their offering. --> ... announced the addition of the "Global ...
(Date:2/3/2016)... http://www.researchandmarkets.com/research/d8zjcd/emotion_detection ) ... "Emotion Detection and Recognition Market by Technology ... Tools (Facial Expression, Voice Recognition and Others), ... Global forecast to 2020" report to ... ) has announced the addition of the ...
Breaking Biology News(10 mins):